Gyre Therapeutics, Inc. (GYRE)

Gyre Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	36.49	11.81	33.51	25.18
Short-Term Investments	17.87	14.86	-	-
Cash & Short-Term Investments	54.37	26.67	33.51	25.18
Cash Growth	116.59%	-20.41%	33.10%	-
Accounts Receivable	24.63	19.59	15.16	15.61
Other Receivables	0.23	5.19	1.29	-
Receivables	25.36	29.15	16.84	17.14
Inventory	8.86	6.34	4.28	6.12
Prepaid Expenses	2.7	1.19	1.55	0.38
Other Current Assets	-	1.44	1.05	0.84
Total Current Assets	91.29	64.79	57.22	49.65
Property, Plant & Equipment	24.9	25.7	23.78	18.38
Long-Term Investments	21.53	24.57	23.43	7.39
Other Intangible Assets	4.96	1.71	1.7	1.86
Long-Term Deferred Tax Assets	6.13	5.62	4.7	4.08
Other Long-Term Assets	3.84	3.03	5.72	3.39
Total Assets	152.65	125.41	116.54	84.75
Accounts Payable	0.07	0.11	0.36	0.12
Accrued Expenses	12.73	9.3	10.56	6.77
Current Portion of Leases	0.62	0.71	0.21	0.49
Current Income Taxes Payable	1.08	2.83	5.05	2.1
Current Unearned Revenue	0.1	0.16	0.08	0.17
Other Current Liabilities	2.32	6.41	3.79	2.59
Total Current Liabilities	16.92	19.52	20.05	12.24
Long-Term Leases	0.77	0.89	0.2	0.12
Long-Term Unearned Revenue	0.88	0.93	0.21	0.12
Other Long-Term Liabilities	4.63	5.68	17.61	0.06
Total Liabilities	23.2	27	38.07	12.54
Common Stock	0.09	0.09	0.08	0.06
Additional Paid-In Capital	161.44	136.19	68.18	32.8
Retained Earnings	-67.22	-70.36	-82.44	10.06
Comprehensive Income & Other	-2.29	-2.6	-1.64	-0.39
Total Common Equity	92.03	63.32	-15.83	42.52
Minority Interest	37.42	35.08	29.78	29.7
Shareholders' Equity	129.44	98.4	78.47	72.22
Total Liabilities & Equity	152.65	125.41	116.54	84.75
Total Debt	1.39	1.6	0.41	0.61
Net Cash (Debt)	52.97	25.07	33.1	24.56
Net Cash Growth	128.88%	-24.25%	34.76%	-
Net Cash Per Share	0.52	0.25	0.50	0.32
Filing Date Shares Outstanding	90.83	93.61	85.42	63.59
Total Common Shares Outstanding	90.82	86.31	76.6	63.59
Working Capital	74.37	45.27	37.17	37.41
Book Value Per Share	1.01	0.73	-0.21	0.67
Tangible Book Value	87.06	61.61	-17.53	40.67
Tangible Book Value Per Share	0.96	0.71	-0.23	0.64
Buildings	19.09	18.98	12.29	10.84
Machinery	10.35	10.28	7.39	5.69
Construction In Progress	0.39	0.22	7.88	4.85
Leasehold Improvements	-	-	-	0.33

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q